Sandoz

Price caps are a band aid hiding larger issues

Read more

Novartis’s Sandoz licenses proposed multiple sclerosis biosimilar

Read more

Sandoz, Macleods Pharma recall two drugs made in India

Read more

EMA accepts Sandoz application for biosim etanercept

Read more

Regulatory submission for Sandoz’ proposed biosimilar pegfilgrastim accepted by FDA

Read more

Sandoz launches Zarxio, the first biosimilar in US

Read more

Pfizer India to shut down Thane plant from September 16

Read more

CPhI Worldwide announces members of its 2015 expert panel

Read more

CCI approves multi-billion dollar deal between GlaxoSmithKline and Novartis

Read more